title: Liposomal-doxorubicin in human immunodeficiency virus-associated Kaposi's sarcoma.
authors.forename: I
authors.initials: I
authors.lastname: Poizot-Martin
authors.forename: M
authors.initials: M
authors.lastname: Giovannini
authors.forename: R
authors.initials: R
authors.lastname: Rosello
authors.forename: J R
authors.initials: JR
authors.lastname: Viallat
authors.forename: J F
authors.initials: JF
authors.lastname: Sauniere
authors.forename: A M
authors.initials: AM
authors.lastname: Dalmas
authors.forename: D
authors.initials: D
authors.lastname: Genre
authors.forename: C
authors.initials: C
authors.lastname: Dhiver
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
mesh_terms: D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008081:Liposomes; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin